研究设计与统计指南

订阅

MedSci主页 / 所有栏目 / 研究设计与统计指南

复杂性尿路感染抗菌药物临床试验技术指导原则（2020年）

2020-12-31 国家药品监督管理局药品审评中心（CDE） NMPA

尿路感染

复杂性尿路感染抗菌药物临床试验技术指导原则

中文标题：

复杂性尿路感染抗菌药物临床试验技术指导原则（2020年）

发布机构：

国家药品监督管理局药品审评中心（CDE）

发布日期：

2020-12-31

简要介绍：

复杂性尿路感染抗菌药物临床试验技术指导原则

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3815a1c0020521f0, title=复杂性尿路感染抗菌药物临床试验技术指导原则（2020年）, enTitle=, guiderFrom=NMPA, authorId=0, author=, summary=复杂性尿路感染抗菌药物临床试验技术指导原则, cover=, journalId=0, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心（CDE）, associationIntro=国家药品监督管理局药品审评中心（CDE）, copyright=0, guiderPublishedTime=Thu Dec 31 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>复杂性尿路感染抗菌药物临床试验技术指导原则</p>, tagList=[TagDto(tagId=355, tagName=尿路感染)], categoryList=[CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=30, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2152, appHits=223, showAppHits=0, pcHits=599, showPcHits=1924, likes=1, shares=7, comments=9, approvalStatus=1, publishedTime=Wed Feb 10 16:05:44 CST 2021, publishedTimeString=2020-12-31, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=fbzhang, createdTime=Tue Feb 09 14:23:23 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Fri Jan 05 17:26:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1201197, encodeId=5a01120119e49, content=指南是医者的规范, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85dc2649927, createdName=8311157908, createdTime=Thu Mar 10 10:41:17 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192418, encodeId=c4bb119241800, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed095084205, createdName=145bca43m13暂无昵称, createdTime=Fri Feb 11 18:27:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192417, encodeId=dc15119241e36, content=太有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed095084205, createdName=145bca43m13暂无昵称, createdTime=Fri Feb 11 18:26:53 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182361, encodeId=20441182361b3, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInKXicNEfukh2V3tGg7PXNec6RqsibDoEMxFiaXzwZ9pKAhj6Jgx3ekSf1XrS3HzVevwRic1SeiamK9jA/132, createdBy=90f95312630, createdName=little monster, createdTime=Sat Jan 08 21:54:16 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082136, encodeId=567d108213690, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d9a5484071, createdName=ms2000000732464271, createdTime=Mon Dec 20 16:30:29 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-03-10 8311157908

    指南是医者的规范

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1201197, encodeId=5a01120119e49, content=指南是医者的规范, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85dc2649927, createdName=8311157908, createdTime=Thu Mar 10 10:41:17 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192418, encodeId=c4bb119241800, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed095084205, createdName=145bca43m13暂无昵称, createdTime=Fri Feb 11 18:27:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192417, encodeId=dc15119241e36, content=太有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed095084205, createdName=145bca43m13暂无昵称, createdTime=Fri Feb 11 18:26:53 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182361, encodeId=20441182361b3, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInKXicNEfukh2V3tGg7PXNec6RqsibDoEMxFiaXzwZ9pKAhj6Jgx3ekSf1XrS3HzVevwRic1SeiamK9jA/132, createdBy=90f95312630, createdName=little monster, createdTime=Sat Jan 08 21:54:16 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082136, encodeId=567d108213690, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d9a5484071, createdName=ms2000000732464271, createdTime=Mon Dec 20 16:30:29 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-02-11 145bca43m13暂无昵称

    。。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1201197, encodeId=5a01120119e49, content=指南是医者的规范, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85dc2649927, createdName=8311157908, createdTime=Thu Mar 10 10:41:17 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192418, encodeId=c4bb119241800, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed095084205, createdName=145bca43m13暂无昵称, createdTime=Fri Feb 11 18:27:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192417, encodeId=dc15119241e36, content=太有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed095084205, createdName=145bca43m13暂无昵称, createdTime=Fri Feb 11 18:26:53 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182361, encodeId=20441182361b3, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInKXicNEfukh2V3tGg7PXNec6RqsibDoEMxFiaXzwZ9pKAhj6Jgx3ekSf1XrS3HzVevwRic1SeiamK9jA/132, createdBy=90f95312630, createdName=little monster, createdTime=Sat Jan 08 21:54:16 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082136, encodeId=567d108213690, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d9a5484071, createdName=ms2000000732464271, createdTime=Mon Dec 20 16:30:29 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-02-11 145bca43m13暂无昵称

    太有用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1201197, encodeId=5a01120119e49, content=指南是医者的规范, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85dc2649927, createdName=8311157908, createdTime=Thu Mar 10 10:41:17 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192418, encodeId=c4bb119241800, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed095084205, createdName=145bca43m13暂无昵称, createdTime=Fri Feb 11 18:27:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192417, encodeId=dc15119241e36, content=太有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed095084205, createdName=145bca43m13暂无昵称, createdTime=Fri Feb 11 18:26:53 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182361, encodeId=20441182361b3, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInKXicNEfukh2V3tGg7PXNec6RqsibDoEMxFiaXzwZ9pKAhj6Jgx3ekSf1XrS3HzVevwRic1SeiamK9jA/132, createdBy=90f95312630, createdName=little monster, createdTime=Sat Jan 08 21:54:16 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082136, encodeId=567d108213690, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d9a5484071, createdName=ms2000000732464271, createdTime=Mon Dec 20 16:30:29 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-01-08 little monster

    太有用了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1201197, encodeId=5a01120119e49, content=指南是医者的规范, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85dc2649927, createdName=8311157908, createdTime=Thu Mar 10 10:41:17 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192418, encodeId=c4bb119241800, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed095084205, createdName=145bca43m13暂无昵称, createdTime=Fri Feb 11 18:27:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192417, encodeId=dc15119241e36, content=太有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed095084205, createdName=145bca43m13暂无昵称, createdTime=Fri Feb 11 18:26:53 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182361, encodeId=20441182361b3, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInKXicNEfukh2V3tGg7PXNec6RqsibDoEMxFiaXzwZ9pKAhj6Jgx3ekSf1XrS3HzVevwRic1SeiamK9jA/132, createdBy=90f95312630, createdName=little monster, createdTime=Sat Jan 08 21:54:16 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082136, encodeId=567d108213690, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d9a5484071, createdName=ms2000000732464271, createdTime=Mon Dec 20 16:30:29 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2021-12-20 ms2000000732464271

    太有用了

    0

相关指南

单纯性尿路感染抗菌药物临床试验技术指导原则（2020年）

国家药品监督管理局药品审评中心（CDE） · 2020-12-31

2020 瑞士共识建议：儿童尿路感染

国外泌尿外科相关专家组（统称） · 2020-07-03

2020 JSPU指南：儿童膀胱输尿管反流的医学管理

国外泌尿外科相关专家组（统称） · 2020-04-01

2018 AUGS最佳实践声明：成年女性反复发作性尿路感染

美国妇科泌尿协会(AUGS,The American Urogynecologic Society) · 2018-01-24

2016 尿路感染临床微生物实验室诊断操作规范

暂未更新 · 2016-07-21

2016 卫生行业标准-尿路感染临床微生物实验室诊断（WS/T489-2016）

暂未更新 · 2016-07-07